英国发现淋球菌出现抗药性 未来淋病或无法治愈（Neisseria gonorrhoeae is resistant to future gonorrhea or incurable in Britain）.docVIP

英国发现淋球菌出现抗药性 未来淋病或无法治愈（Neisseria gonorrhoeae is resistant to future gonorrhea or incurable in Britain） Author: Morrowind source: Sina Technology released time: 2011-10-13 13:03:49 Choose size: small, medium, large Neisseria gonorrhoeae is resistant to future gonorrhea or incurable in Britain The incidence of gonorrhea in the UK is on the decline this year, but a slight rebound in 2010. Beijing on October 13th news, British doctors told the day before, they originally used antibiotics in the treatment of gonorrhea is no longer valid, because the cause of sexually transmitted diseases are bacteria develop resistance. The British Health Protection Agency (HPA) says we may soon be at a tipping point when we can do nothing about the disease unless new therapies emerge. At this stage, doctors must begin to discontinue the use of cefixime, a routine drug used before treatment, and switch to two more powerful antibiotic drugs. One is an oral tablet and the other is an injection. The UK health protection agency believes it is essential to adopt more powerful drugs in the face of improved antimicrobial activity. The 2010 test showed that the obtained from patients with gonococcal strains, and cultured in the laboratory, there are about 20% showed sensitivity to antibiotics cefixime decreased, the figure in 2009 was only 10%. In 2005, Neisseria gonorrhoeae found in the UK did not find any case of a decline in the sensitivity of the drug to cefixime. The causative agent of gonorrhea is caused by Neisseria gonorrhoeae, commonly known as Neisseria gonorrhoeae. This bacterium has the ability to regulate itself, acquire resistance by mutating, or at least reduce the efficacy of the drug, and it is developing this immunity for a growing number of antibiotics. Penicillin failed first, then tetracycline, ciprofloxacin, and now cefixime. In response to the situation, the WHO recommended that countries should consider replacing first-line antibiotic drugs when hospitals find about 5% fa